This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Cox PH. European legislation and its effects on the production of radiopharmaceuticals. In: Sampson CB, ed. Textbook of Radiopharmacy. Amsterdam: Gordon and Breach Science Publishers; 1999.
Gollnick DA. Basic Radiation Protection Technology. 2nd ed. Altadena, CA: Pacific Radiation Corporation; 1988.
International Commission on Radiological Protection. General principles for the radiation protection of workers. ICRP 75. New York: Elsevier; 1997.
International Commission on Radiological Protection. 1990 recommendations of the ICRP. ICRP 60. New York: Elsevier; 1990.
National Council on Radiation Protection and Measurements. Limitation of exposure to ionizing radiation (NCRP 116). Bethesda, MD: NCRP Publications; 1993.
National Council on Radiation Protection and Measurements. Maintaining radiation protection records (NCRP 114). Bethesda, MD: NCRP Publications; 1992.
National Council on Radiation Protection and Measurements. Nuclear medicine factors influencing the choice and use of radionuclides in diagnosis and therapy (NCRP 70). Bethesda, MD: NCRP Publications; 1982.
National Council on Radiation Protection and Measurements. Radiation protection and allied health personnel (NCRP 105). Bethesda, MD: NCRP Publications; 1989.
Nuclear Regulatory Commission. Consolidated guidance about material licenses: program specific guidance about medical license. NUREA-1556, Vol 9. Washington DC; 1998.
Nuclear Regulatory Commission. Medical Use of Byproduct Material. 10CFR Part 35. Washington, DC; 2002.
Nuclear Regulatory Commission. Standards for protection against radiation. 10CFR Part 20. Washington, DC; 1995.
Shapiro J. Radiation Protection. 4th ed. Cambridge, MA: Harvard University Press; 2002.
U.S. Food and Drug Administration. Food and Drug Administration Modernization Act of 1997. Rockville, MD: 1997.
U.S. Food and Drug Administration. Nuclear pharmacy guideline: criteria for determining when to register as a drug establishment. Washington, DC: 1984.
U.S. Food and Drug Administration. Radioactive drugs and radioactive biological products. Fed Register. 1975; 40:144.
U.S. Food and Drug Administration. Regulations for in vivo radiopharmaceuticals for diagnosing and monitoring. 21CFR Part 315. Rockville, MD: 1999.
Rights and permissions
Copyright information
© 2004 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
(2004). Radiation Regulations, Protection, and Uses. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/0-387-21702-9_11
Download citation
DOI: https://doi.org/10.1007/0-387-21702-9_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-40360-1
Online ISBN: 978-0-387-21702-4
eBook Packages: Springer Book Archive